Home | CommonSpirit Health

Oxford Biomedica has agreed to produce several million doses, with potential to scale up into the tens of millions if it works. James Miskin, the company’s chief technical officer, describes a multistep production process that sounds to my layperson’s ears like a cross between making a sourdough starter and boiling down sap to make maple syrup. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download